Psychology of consciousness (Washington, D.C.)
March 1, 2019
Benjamin Baird, Brady A Riedner, Melanie Boly et al.
41 citations
Lucid dreaming occurs more often in long-term meditators than in people who do not meditate. Among non-meditators, lucid dream frequency is linked to the ability to put experience into words, while among meditators it is linked to observing and decentering aspects of mindfulness. However, an 8-week mindfulness course did not increase lucid dream frequency. The findings suggest a continuity between awareness during waking and sleeping states and connect meditation training with meta-awareness, but the precise nature of the link remains unclear.
Translational psychiatry
September 12, 2024
Christopher R Nicholas, Matthew I Banks, Richard C Lennertz et al.
10 citations
Psilocybin, a serotonergic psychedelic, can relieve symptoms in several psychiatric disorders and improve well-being, but it was unclear whether these benefits arise during the acute experience or depend on later memory of it. In 8 healthy participants, psilocybin (25 mg) was co-administered with the amnestic benzodiazepine midazolam at a dose that allowed a conscious psychedelic experience while partially impairing memory for it. Higher midazolam doses and greater memory impairment tended to associate with lower salience, insight, and well-being from psilocybin. These results suggest memory plays a role in therapeutically relevant behavioral effects of psilocybin.
Translational psychiatry
February 14, 2026
Michael H Sutherland, Christopher R Nicholas, Richard C Lennertz et al.
Psilocybin, a serotonergic psychedelic, induces neural plasticity and alters consciousness, while midazolam, a benzodiazepine, blunts plasticity and induces sedation. In an open-label pilot study, 25 mg of oral psilocybin was given alongside intravenous midazolam at doses that allowed a full psychedelic experience but blunted memory. Electroencephalography (EEG) data showed that 15–30 minutes after dosing, when midazolam was at its target concentration, beta power increased and spectral exponent decreased. As psilocybin's effects emerged over the next six hours, Lempel-Ziv complexity and spectral exponent increased, while broadband power decreased, especially in delta, theta, and alpha bands. The findings suggest psilocybin's effects persist with midazolam, supporting its use in mechanistic studies.